Salk scientists demonstrate B cells directly enhance killer T cell function
Cancer is the second leading cause of death in the United States, according to a 2026 Cancer Research…
MD Anderson trial challenges local consolidative therapy paradigm in NSCLC
Adding local consolidative therapy (LCT) after induction treatment with nivolumab plus ipilimumab did not improve overall survival or…
New integrated framework advances precision surgery for liver cancer
Hepatocellular carcinoma is the sixth most common malignancy and the third leading cause of cancer-related death globally. Despite…
Vitamin A derivative prevents immune cell exhaustion in brain tumors
Immune cells can become exhausted after prolonged exposure to cancer, gradually losing their ability to attack tumor cells.…
Microscopic peptide droplets reduce colorectal tumor growth in mice
Scientists from Nanyang Technological University, Singapore (NTU Singapore) have developed microscopic peptide droplets that deliver large amounts of…
Children’s Colorado launches new program to expand treatment options for children with food allergies
Children’s Hospital Colorado’s Allergy and Immunology Center today launched its Sublingual Immunotherapy Program at its Anschutz Medical Campus…
Immunotherapy shows potential for treating rising gynecological tumors
Gynecological tumors, including cervical cancer (CC), endometrial cancer (EC), and ovarian cancer (OC), represent a significant global health…
Study shows how cancer can act as a systemic disease
In their quest to understand how cancers take root, grow and spread, scientists have for the past half-century…
UC Irvine researchers develop framework to make CAR T-cell therapy safer
CAR T-cell therapy has transformed cancer care, offering new hope to patients with aggressive blood cancers who once…
Preoperative combination therapy improves head and neck cancer outcomes
Bottom line: Patients with head and neck cancer who received chemotherapy in addition to immunotherapy before surgery had…
Genetic tool turns soft cancer cells into immune targets
Researchers at the USC Viterbi School of Engineering and Keck School of Medicine of USC have engineered a remarkable genetic tool that…
Discovery may help develop new treatments for immunosuppressed skin cancer patients
Researchers at The University of Texas MD Anderson Cancer Center have discovered that immunosuppressed patients with non-melanoma skin cancer are not missing the key cancer-fighting immune cells found in immunocompetent patients, but those…